The Valley Desk

NCT01429116 · Interventional trial

Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

Overall registry status Completed

Phase 3

Conditions Non-24-Hour Sleep-Wake Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov